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Microglial activation induces 
neuronal death in Chandipura virus 
infection
Abhishek Kumar Verma, Sourish Ghosh, Sreeparna Pradhan† & Anirban Basu
Neurotropic viruses induce neurodegeneration either directly by activating host death domains or 
indirectly through host immune response pathways. Chandipura Virus (CHPV) belonging to family 
Rhabdoviridae is ranked among the emerging pathogens of the Indian subcontinent. Previously we 
have reported that CHPV induces neurodegeneration albeit the root cause of this degeneration is still 
an open question. In this study we explored the role of microglia following CHPV infection. Phenotypic 
analysis of microglia through lectin and Iba-1 staining indicated cells were in an activated state post 
CHPV infection in cortical region of the infected mouse brain. Cytokine Bead Array (CBA) analysis 
revealed comparatively higher cytokine and chemokine levels in the same region. Increased level of 
inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), Nitric Oxide (NO) and Reactive 
Oxygen species (ROS) in CHPV infected mouse brain indicated a strong inflammatory response to 
CHPV infection. Hence it was hypothesized through our analyses that this inflammatory response may 
stimulate the neuronal death following CHPV infection. In order to validate our hypothesis supernatant 
from CHPV infected microglial culture was used to infect neuronal cell line and primary neurons. This 
study confirmed the bystander killing of neurons due to activation of microglia post CHPV infection.
Inflammation as reported previously is a “double edged sword” for CNS1. Cases of chronic inflammation have 
been reported to cause tissue damage often leading to organ failures. In Central Nervous System (CNS) chronic 
inflammation results in neurodegeneration. Microglia are mesodermal cells of the brain that are activated under 
pathological conditions and tissue damage2,3. Transformation from resting to active state stimulates microglia to 
release various factors including cytokines, reactive oxygen species (ROS) and nitrogen species. Evidences have 
shown that although controlled level of release of these factors have a protective role, but an uncontrolled release 
of these factors in chronic conditions have a deleterious effect on neurons. Neurodegeneration is a common 
phenomenon that has been reported in cases of several neurotropic virus infections4–6. Under such condition 
of pathogenic attack microglia gets activated that subsequently leads to amplified secretion of the cytokines and 
chemokines that have been reported to kill the neurons in the vicinity of activation. This is presently termed as 
“bystander killing of neurons” where the neurons are forced to undergo apoptotic or necrotic death following 
external signalling from the microglia7–11. Bystander killing of neurons following viruses has been evidenced in 
various cases of neurotropic viral infections. But reports differ in their mechanistic view of this phenomenon.
CHPV was first isolated in the village of Chandipura, a small village in the district of Nagpur, Maharashtra, 
India while diagnosing people suffering from an unknown fever. Initially the researchers were suspect-
ing the cause to be dengue or chikungunya virus but later it was identified to be belonging to the family of 
Rhabdoviridae12. Since the patients were not dying due to this virus infection researchers were reluctant to inves-
tigate on this virus. Moreover, there was no direct evidence that proved the virus was potent to cause symptomatic 
effect in the human patients. But with the sudden outbreak of epidemic in the Indian subcontinent in the year 
2003, researchers started to investigate the causal pathogen. It was found as a result of several researches that 
CHPV has presently distanced itself from its sibling Vesiculovirus (which also does not have any human case 
reported) and has resulted in the massive outbreak13. Chandipura virus (CHPV) is a (− ) single-stranded RNA 
virus. Phlebotomus sps. is the known vector for this virus14,15. Children under 15 years of age are more susceptible 
to this virus. CHPV has been reported to be an emerging human pathogen in the Indian subcontinent, with a 
case fatality of around 55 to 77%16–19. The symptoms are similar to other encephalitis attacks as characterized 
by acute fever, altered sensorium, seizures, diarrhoea, and vomiting. It has been reported previously that mouse 
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dies post CHPV infection within 72–96 hours20. CHPV genome length is of 11 kb, comprised of 5 genes which 
encode a glycoprotein (G), a matrix protein (M), a nucleoprotein (N), a phosphoprotein (P protein), and a large 
polymerase protein (L).
For the past decade this virus is under the radar of investigation and researchers have gathered much infor-
mation regarding its mode of replication and about its genome. But the host response and the neuropathogenesis 
of this virus was still an untold story. Neurons are safe place for replication and maturation of CHPV and it has 
been reported from our lab that this virus is not infecting astrocytes and microglia21. In this report we have 
explored the phenomenon of microglial activation pattern due to CHPV infection and measured the amount of 
pro-inflammatory cytokines secreted in different regions of the mouse brain post infection. According to previ-
ous studies reported from our lab CHPV induced direct killing of the neurons post infection through extrinsic 
apoptotic pathway20. But the source of the induction of apoptotic pathway is still unknown. In order to find an 
answer to this we hypothesized that microglial activation may have some pivotal role to play by bringing about 
the bystander killing of the neurons post CHPV infection.
Results
Evaluation of neurodegeneration in various brain regions post CHPV infection. Mouse brain 
sections from cortex, hippocampus, thalamus and striatum were stained with Nissl for analysing the neuronal 
population post CHPV infection. Nissl positive cells from corresponding areas of CHPV infected tissue were 
counted and compared with that of the mock infected sections. Counting was done from 5 separate sections 
(both CHPV and mock infected) from 3 independent experiments. Analysis showed significant reduction in neu-
ronal population in cortical and hippocampal regions compared to mock infected sections (Fig. 1A,C). Further 
double staining of NeuN with TUNEL showed comparatively higher NeuN-TUNEL positive cells in the cortical 
and hippocampal regions when compared to other regions (Fig. 1B,D). NeuN-TUNEL positive cell population 
was found to be least in striatal areas. Neun-TUNEL positive cells represent neuronal death. Since the neuronal 
death was found to be occurring differentially in various brain regions as per the Nissl and TUNEL staining 
results, we were interested to know whether the neurodegeneration was corresponding to a certain pattern of 
Figure 1. Evaluation of neuronal death post CHPV infection across the various brain regions.  
(A) Represents distribution of neuron in different brain regions. Dead cells are lightly stained or unstained 
indicated by arrow heads. (B) Co-expression of neuronal marker (NeuN) and cell death marker (TUNEL) 
represents the neurons undergoing apoptosis. (C) Representative graph shows analysis of cell counted for 
Nissl stain from an equivalent area from separate sections. (D) Representative graph shows percentage of 
neurodegeneration in different brain region. Calculated as: Percentage of dead cells = (Number of cells 
co-expressing NeuN and TUNEL)/Number of cells expressing NeuN) ×100. (E) Representative graph 
demonstrates qPCR mRNA level of viral P-Protein from different brain regions. *p < 0.05,**p < 0.01 and 
***p < 0.005.
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infection of CHPV in the brain. Quantitative PCR (qPCR) was performed to analyse the viral infection in differ-
ent brain regions. Fig.1E indicated that there is no significant difference in viral replication irrespective of brain 
regions. Hence at this point we can state that CHPV infected and replicated in the brain without any bias to a par-
ticular region of the brain although there is a significant difference in neurodegeneration across the brain regions.
Topographic distribution and activation pattern of Microglia following CHPV infection in 
brain. Under the pathological conditions microglia undergo a series of stereotyped, morphological, pheno-
typic and functional changes in response to an activating stimulus. We examined the response of this resident 
immune cell of the CNS to CHPV infection in different brain regions. Lectin staining defines the microglial mor-
phology. Using this histochemical stain, we have shown the presence of resting or quiescent cells exhibiting long 
thin rod like processes in mock infected animals. Following infection, the resting microglia decrease in number 
and were replaced by numerous “reactive microglial cells” with thicker processes and star-shaped morphology. 
Further microglia transformed from activated to amoeboid or phagocytic form by attaining rounded, darkly 
stained cell morphology. In the infected brain, the number of star-shaped “reactive” or “activated” microglia was 
more in the cortex compared to thalamus, striatum and hippocampus. These results indicated that CHPV infec-
tion is accompanied by robust microglial activation. We therefore determined the topographic distribution of 
resting, activated and phagocytic microglia in different brain region. 5 fields of lectin stained sections of infected 
brain were chosen for each region. Lightly stained rod-shaped cells were counted as resting cells, star-shaped 
cells as reactive cells and darkly stained round or triangular shaped cells were considered as amoeboid cells. 
Cells of each type were counted from five different sections and standard deviation across mean was calculated 
(Fig. 2A,C).
The result obtained from counting morphologically different cells showed that post CHPV infection resting 
cells have been transformed into activated morphology and the activated cells are maximum in cortex, hippocam-
pus followed by striatum and thalamus. Lectin staining has shown the presence of amoeboid morphology that 
is significantly high in cortical and hippocampal regions (Fig. 2C). As a part of validation study tissue sections 
were further stained with Iba-1, a microglial marker. Different morphologies of microglia were obtained showing 
maximum activation in cortex followed by hippocampus (Fig. 2B). The activated microglia was least in striatum 
Figure 2. Topographic distribution and activation pattern of Microglia following CHPV infection in 
brain. (A) Lectin staining shows clear morphology of microglia in mock and CHPV infected brain tissue 
sample. Arrow heads a, b, and c shows resting, activated and phagocytic state respectively of microglia. 
(B) Iba-1 staining shows activated morphology of microglia which is greater in cortex and hippocampus 
when compared with thalamus and striatum. (C) Representative graph evaluates the number of microglia 
acquiring different morphological state after CHPV infection in different brain regions. (D) Representative 
graph shows quantitative analysis of resting and activated microglial morphology in different brain regions 
with Iba-1 staining. *p < 0.05 and ***p < 0.005.
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and thalamus. The representative graph compared number of activated microglia in mock infected and CHPV 
infected sections (Fig. 2D). A time dependent analysis of microglial activation was also observed by Iba-1 staining 
in vivo that showed an increasing number of activated microglia post CHPV infection (Fig. S1 A,B). Plaque assay 
analysis demonstrated that the microglial activation correlates with the propagation of CHPV in brain (Fig. S1C).
Hence Fig. 1 and 2 concomitantly proved that both cortex and hippocampus are affected by CHPV infection. 
These results prompted us to explore the probability of bystander killing of neurons by microglial activation.
Proinflammatory cytokine and chemokine profile post CHPV infection. Chronic activation of 
microglia stimulates release of cytokines and chemokines that have deleterious effect on neurons. We investigated 
the functional profile of activated microglia following CHPV infection in BV2 cells at 8, 16 and 24 hours post 
infection (hpi) as well as at 48 and 72 hpi from various regions of brain. CBA and qPCR analysis was performed 
to monitor the pro-inflammatory cytokine and chemokine levels in the BV2 lysate and brain homogenates 
(Fig. 3 and Fig. S2). CBA analysis showed significant enhancement of IL-6 level in BV2 cells at different time 
points and the highest fold change over control was at 24 hpi (Fig. 3A). In case of in vivo, a 6 & 5 fold change in 
expression level of IL-6 was observed in cortex and hippocampus, respectively at 72 hpi. Expression level of IL-6 
showed an increasing trend in cortex, hippocampus and striatum in the course of CHPV infection except in case 
of thalamus (Fig. 3C). Similar to IL-6, CCL2 showed significant increase in its level over the time points in case of 
BV2 cells (Fig. 3B). CBA analysis indicated a robust increase in the level of CCL2 in cortex, hippocampus, thala-
mus as well as in striatum. The fold change over control for CCL2 was more in 72 hpi than at 48 hpi that was found 
to be consistent in all areas. Maximum fold change in CCL2 level was observed in cortex at both 48 as well as 72 hpi 
(Fig. 3D). A similar trend was observed in case of qPCR analysis (Fig. S2). A dose dependent study of cytokine 
level was conducted with different viral doses at 0.01 MOI, 1 MOI and 10 MOI and in presence of UV inactivated 
virus. No significant increase in IL-6 and CCL2 level was observed in case of UV inactivated virus (Fig. S3). Low 
viral dose was unable to elicit cytokine response whereas at higher dose IL-6 and CCL2 level showed an increasing 
trend over the time points. Interferon level was measured using ELISA from BV2 cell lines as well as from Brain 
lysate. We didn’t find significant difference in IFN-β and IFN-γ levels in supernatant collected at 8 hpi and 16 hpi 
from CHPV infected cells when compared with their corresponding mock infected samples. 1.4 fold change in 
IFN-β and 1.47 fold change in IFN-γ level was found at 24 hpi supernatant that was found to be significantly high 
(Fig. S4 A,B). Similarly ELISA for IFN-β from whole brain lysate showed 1.4 and 2.2 fold change at 48 hpi and 
72 hpi, respectively, when compared with mock infected sample (Fig. S4C). IFN-γ also increased at later time 
points of infection when compared with mock infected samples (Fig. S4D).
Induction of iNOS and COX-2 following CHPV infection. Inducible nitric oxide synthase (iNOS) pro-
duces a large amount of nitric oxide (NO) in response to inflammatory mediators. We compared the mRNA levels 
Figure 3. Topographic analysis of pro-inflammatory cytokines using CBA method. Protein from different 
brain region was isolated and inflammation was measured. (A) shows IL-6 level in BV2 lysate post CHPV 
infection at different time points. (B) CCL-2 level was measured in BV2 cells. (C,D) CBA was performed from 
brain lysate. IL-6 and CCL-2 was measured at 48 hpi and 72 hpi. *P < 0.05, **P < 0.01 and ***P < 0.0005.
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of iNOS in BV2 cells at 8, 16 and 24 hpi and mouse brains at 48 and 72 hpi with mock infected. We performed 
immunohistochemistry to detect the expression of COX-2 and iNOS in mock infected and CHPV infected 
mouse brain sections. Expression of COX-2 increased following infection. Co-localization of COX-2 and Iba-1 
in infected animals established that activated microglia released COX-2 following CHPV infection (Fig. 4A). 
Double staining using Iba-1 and iNOS antibody showed significantly higher number of double positive cells in 
infected sections compared to the mock infected sections (Fig. 4B). qPCR analysis indicated a 47 and 38 fold 
increase in the level of COX-2 while a 6 and 2 fold increase in the expression of iNOS was observed at 48 and 
72 hpi, respectively when compared with their corresponding mock infected samples (Fig. 4C,D).
Measurement of ROS and NO secreted from CHPV microglial cells. Generation of reactive oxygen 
species (ROS) and nitric oxide (NO) by microglial cells in response to infection is a key marker for oxidative 
stress in these cells. We therefore measured level of ROS and NO from BV2 cells (Fig. 5A,B). ROS from different 
regions of brain as previously mentioned was also analyzed (Fig. 5C). Both ROS and NO levels were checked at 
different incubation time points and were found to increase consistently with time. Level of NO was found to be 
significantly higher at 16 hpi that decreased further (Fig. 5A). ROS level in CHPV infected sample was signifi-
cantly higher in 24 hpi compared to mock infected ones (Fig. 5B). ROS measurement from tissue lysate showed 
significantly higher level of ROS generation from cortex and hippocampus regions.
Bystander neuronal killing by microglial activation. Finally, in order to validate the bystander kill-
ing of neurons by activated microglia, primary cortical neurons along with HT-22 cell lines were treated with 
UV-treated supernatant collected from BV-2 cells. UV-treatment as mentioned in the methods section removed 
viral contamination from the cell supernatant. Hence we made sure that there was no pathogenic agent in the 
supernatants to induce the neuronal killing. Immunocytochemistry was performed to assess cell death in vitro 
using TUNEL staining. Neuronal cells treated with supernatant obtained from CHPV infected microglia showed 
significantly higher number of TUNEL positive cells compared to mock infected cells (Fig. 6A). For further 
validation of our hypothesis similar experiment was conducted in HT-22 cell line. TUNEL staining was per-
formed. TUNEL positive cells were significantly higher compared to mock infected cells (Fig. 6B). These analyses 
indicated that microglial supernatant contained pro-inflammatory mediators that had lethal effect on neurons. 
Further, to confirm apoptosis caspase-3 level was monitored in HT-22 cell using immunoblotting. Blot analysis 
Figure 4. CHPV infection induces iNOS and COX-2 expression in brain. (A) Immunohistochemitry 
analysis of COX-2 and Iba-1 from mice brains after CHPV infection. Images represents COX-2 increased 
expression when compared with mock infected. Image in inset is of 63× magnification depicts colocolisation 
of COX-2 with Iba-1. (B) Immunohistochemitry images showing increased expression of iNOS from brain 
sections as compared to mock infected. Inset image is showing colocolisation of iNOS with Iba-1. mRNA level 
of COX-2 and iNOS was quantified using real time PCR. (C) Analysis of inducible nitric oxide synthase (iNOS), 
cyclooxygenase-2 (COX-2) from BV2 cells. (D) shows mRNA level in mouse brain at 48 hpi and 72 hpi. Values 
were normalized to GAPDH. *p < 0.05 and **p < 0.01.
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showed cleavage of caspase-3 in supernatant treated cell lysate (Fig. 6C). Plaque assay was performed to confirm 
virus free supernatant showing no plaques in UV treated supernatant (Fig. 6D).
Discussions
Neurodegeneration in case of Chandipura Virus (CHPV) infection has been a well-known fact for some time 
now. Previously, our lab reported that neuronal death post CHPV infection was brought about through Fas- 
mediated extrinsic apoptotic pathway20. But the trigger that stimulated the neurons to undergo apoptosis was 
unknown. Our present study focused on finding that trigger. With the initial studies as suggested by the Fig. 1 we 
observed a significant amount of neurons were undergoing cell death in the cortical and the hippocampal regions 
of the brain post CHPV infection. In order to tally the observed neurodegeneration in those specific brain regions 
with the infection of CHPV we observed that the virus infected all the regions of the brain without a bias. Further 
to explore this result, we monitored the microglial activation in the various brain regions as shown in Fig. 2. 
Earlier reports suggested that microglia are ubiquitous and numerous in the CNS but not uniformly distrib-
uted22,23. Microglial population density is more in the telencephalon, followed by diencephalon, mesencephalon 
and rhombencephalon24. Compared to white matter, grey matter consist of more microglial cells. However, within 
these major divisions there is much heterogeneity in terms of both cell number and membrane density. Fig. 2 
shows more activated and phagocytic microglia in the cortex and hippocampal regions followed by striatum and 
thalamus. Activation pattern of microglia and its corresponding regions related to neurodegeneration motivated 
us to explore the microglial role in neuronal killing.
Bystander killing of neurons through microglial activation has been observed in various cases of neuro-
pathogenesis through viral infection7,25–27. As the primary immune effector cells of the CNS, microglia responds 
to injury, inflammation or the presence of pathogens by transforming to the “activated” state. When activated, 
microglial cells undergo proliferation, chemotaxis, and morphological alteration and generate numerous media-
tors involved in the inflammatory and immune-modulatory response. These mediators not only coordinate tissue 
remodelling in response to damage, but also possess several means by which they protect neurons from infection. 
In case of viral infection the microglial activation often results in chronic inflammation leading to brain death28–
30. Our study has demonstrated for the first time that CHPV infection activates microglia both morphologically 
and functionally, in vivo. CHPV infection leads to an elevated level of pro-inflammatory mediator secretion. 
Microglia are the predominant source of pro-inflammatory mediators, and the cytotoxins released from acti-
vated microglia in cases of chronic infection are instrumental in inducing neuronal death. Our findings therefore 
suggest that microglial activation may be an important contributory factor in the pathogenesis of CHPV. The 
set of mediators that are elevated following CHPV infection consists of pro-inflammatory cytokines that would 
normally be associated with the recruitment of inflammatory cells, to the site of infection. These cytokines could 
Figure 5. Generation of Nitric oxide (NO) and Reactive oxygen species (ROS). (A) NO generation was 
measured from BV2 cells using Griess reagent. The amount of nitrite accumulated was calculated (in μM) from 
a standard curve constructed with different concentrations of sodium nitrite. (B) Representative graph shows 
ROS level in BV2 cells. Level of ROS was maximum at 24 hpi followed by 16 hpi. (C) Plot showing intracellular 
ROS production, after different time of CHPV infection in Brain sample cells were collected from different 
regions and estimated for ROS generation. *p < 0.05, **p < 0.01 and ***p < 0.005.
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contribute to the disruption of the blood brain barrier (BBB) that facilitates additional dissemination of the virus 
within the CNS. Pro-inflammatory cytokines and chemokines released by the microglial activation process bind 
to specific receptors of neurons that initiate the apoptotic mechanism in the cells. In order to validate our find-
ings, we analysed the cytokine and chemokine levels from the brain regions mentioned earlier (Fig. 3). Following 
CHPV infection, expression levels of CCL2 and IL-6 was found to increase that were previously implicated in 
playing positive roles in encephalitis31–34. A region specific study of CCL2 and IL-6 expression reiterated our 
initial findings. Cortex showed the highest release of CCL2 and IL-6 from both 48 and 72 hpi (hours post infec-
tion) compared to other regions. Moreover, we studied the kinetics of the release of both these pro-inflammatory 
elements and observed an increasing trend over the time points (Fig. S2 & S3). These results guided our study in 
search of other deleterious inflammatory molecules.
Several studies have suggested an important role of enzyme inducible nitrogen oxide synthase (iNOS) and 
cycloxygenese-2 (COX-2) in the progression of neuronal damage after exictotoxic and ischemic injury35,36. Our 
further investigation suggested CHPV infection in the brain was followed by encephalitis symptom with the 
over-expression of iNOS and COX-2 (Fig. 4). Analysis from BV 2 cells showed enhanced levels of iNOS and 
COX-2 at 16 hours of infection that later decreased at 24 hpi and was consistent with the in vivo data. The signif-
icant increase in iNOS level at 48 hpi followed by the decline in level (compared to control) at 72 hpi , prompted 
us to speculate the existence of a compensatory mechanism that attempts to reduce the level of inflammation. 
Generation of ROS with the accumulation of oxidative damage has been implicated in neurodegenerative dis-
eases and in the degradation of nervous system function. The brain is particularly vulnerable to oxidative stress 
on account of its high reactive oxygen levels, the presence of polyunsaturated fatty acids, transition metals in 
ionic form and low amounts of antioxidants37. Earlier it was reported that aberrant production of NO leads to 
peroxy-nitrite production can irreversibly damage lipid and protein synthesis causing cell death38. NO enhances 
glutamate excito-toxicity. Elevated level of ROS and NO in our case helped us to conclude that ROS and NO 
are also contributing to neuronal damage (Fig. 5). Although release of these mediators is meant for protection 
from pathogens and other brain insults, but it is also evident that it has irreplaceable deleterious effect in chronic 
infections. Microglia induces death directly by releasing different cytokines and chemokines or indirectly by 
infiltrating monocytes and T cells. In vitro microglial cells get infected and release different pro-inflammatory 
mediators. We have shown that CHPV infected microglial supernatant (UV radiated to remove viral contami-
nation) treatment of both hippocampal neuronal cell line and primary neuronal culture with supernatant from 
Figure 6. Bystander killing of neurons using supernatants from activated microglial cells. (A) In vitro 
cultured mouse cortical neurons were treated with supernatant (UV treated) for 12 hours and TUNEL staining 
was performed. The cells were counterstained with DAPI to study the nuclear morphology. Top panel shows 
staining in untreated cells while the lower panel shows supernatant treated cells. (B) In vitro culture of HT-22 
neuron showed TUNEL positive cells in supernatant treated panel confirming bystander killing of neurons. 
(C) Immunoblot image shows expression of caspase 3 in supernatant treated HT-22 cells. β -actin was used 
as loading control. (D) Plaque assay on vero cell line showing no plaque in UV treated supernatant when 
compared with untreated supernatant.
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microglial activation resulted in neuronal death. Observations from Fig. 6 helped us to conclude that microglial 
activation was stimulating the bystander killing of neurons following CHPV infection. Thus microglial activation 
may be one of the triggering factors for the neuronal apoptosis.
In conclusion, the present study suggested an answer to the question as to what triggers the apoptotic machin-
ery in the neurons post CHPV infection. It would be of our future interest to identify the specific pathway of the 
bystander killing of neurons post CHPV infection. Moreover the existence of other triggering factors for the 
neuronal killing upon CHPV infection cannot be ruled out at this stage. Further research in this area would help 
the researchers to reveal the mechanistic model of neuropathogenesis of CHPV.
Materials and Method
Ethics statement. All animal experiments were approved by the Institutional Animal and Ethics Committee 
of the National Brain Research Centre (approval no. NBRC/IAEC/2013/88). The animals were handled in strict 
accordance with good animal practice as defined by the Committee for the Purpose of Control and Supervision 
of Experiments on Animals, Ministry of Environment and Forestry (CPCSEA), Government of India.
Virus and Cell. CHPV (strain No. 1653514) was isolated from a human patient in Nagpur, 2003; kindly pro-
vided by Dhrubajyoti Chatopadhayay, University of Calcutta. The virus was propagated in the Vero cell line39. The 
titer of virus was analyzed to be 3 × 109 pfu/ml using plaque assay technique as mentioned later in this section. 
HT-22 (immortalized mouse hippocampal neuronal cell line was gifted by Dr. Shiv Kumar Sharma, National 
Brain Research Centre) cells were used for our experiment with prior permission from Dr. Dave Schubert of 
Salk Institute from whom these cells were originally obtained. We also used BV2 cells (mouse microglial cell line, 
obtained from Dr. Steve Levison, Rutgers New Jersey Medical School, USA) to study the microglial response 
post CHPV infection. Both the cell lines mentioned here were grown at 37 °C in Dulbecco’s modified eagle 
medium (DMEM) supplemented with 3.7%, Sodium bicarbonate(Sigma, USA), 10% FBS(Gibco, Thermo Fischer 
Scientific, USA) and penicillin-streptomycin(Sigma, USA).
Animal treatment. 10 days postnatal BALB/c mouse pups were divided into two groups having five pups 
irrespective of sex in each group (since it is known that the virus does not have a gender bias for infection). 
CHPV group was injected with 50 μl of virus (approx. 1.5 × 105 pfu/ml), while the mock infected group was 
injected with an equivalent amount of PBS through the intra-peritoneal (i.p.) route. Animals were sacrificed 
between 72–96 hours post-infection on the development of encephalitic symptoms in the CHPV group. Brains 
were excised after trans-cardial perfusion with ice cold 1X PBS.
For immunohistochemistry (IHC) analyses tissues were fixed using 4% paraformaldehyde (PFA) at 4 °C over-
night after the excision. The following day tissues were dipped in sugar solution for 36 hours until they got fully 
submerged in the solution. After that tissues were processed for cryo-sectioning.
Brain tissues that were excised for RNA and protein extraction after excision were stored at − 80 °C till use.
Infection and treatment of BV2cells. BV2 cells were cultured in 10% serum containing media and were 
seeded in 60 mm plate at the density of 5 × 105. After 12 hours the media was replaced by serum free media to 
limit the growth rate of the cells so that a particular number of cells can be monitored for infection. Post 2 hours 
incubation BV2 cells were infected with CHPV at multiplicity of infection (MOI) 0.1 for 2 hours and then cells 
were washed twice with 1X PBS to remove non internalized virus present in media. Cells at various post infection 
time points were harvested and the culture supernatants were collected and stored at − 80 °C.
HT22 cells were incubated with UV inactivated supernatant of BV2 cell culture for 12 hours. Cells were then 
processed for cell death assay and protein extraction.
CHPV inactivation process. CHPV inactivation was carried out with a UV cross-linker (UVC 500, Hoefer 
scientific, USA) using short-wavelength UV radiation (UVC, 254 nm) at a distance of 5 cm for 25 minutes on ice 
as described earlier40. Inactivation of virus was verified by plaque assay for all three sets of treated supernatant 
which showed the absence of viral plaque formation in the UV treated culture supernatant (Fig. 6C).
Plaque assay. Plaque assay was performed following previously published protocol20. Vero cells were cul-
tured in 10% FBS containing DMEM and seeded in 6 well plates at the density of 4 × 104 cells/well. After complete 
monolayer formation was achieved serum containing media was changed to serum free media and incubated 
for 2 hours to acclimatize the cells for serum starvation. Meanwhile serial dilution was prepared in serum free 
DMEM starting with a 1:10 dilution of the stock solution (by adding 100 μL of UV inactivated supernatant and 
UV untreated supernatant in 900 μL media). The stock solution was serially diluted using 10-fold dilutions. Each 
dilution was added to each well of Vero cells. Post two hour of incubation with the respective dilutions at 37 °C, 
supernatants were removed and washed twice with 1X PBS to avoid multiple infection cycles. 3 ml of agarose 
overlay (9 ml 2% agrose (Roche, Germany), 10 ml 2X Minimal essential media (Sigma, USA), 1 ml FBS (Gibco, 
Thermo Fisher Scientific, USA), 100 μL penicillin-streptomycin (Sigma, USA)) was then added to each well. Plate 
was kept at 4 °C for solidifying the overlay after which it was returned to 37 °C for incubation of 24 hours. 4% PFA 
was added post incubation period for fixation of the cells for further analysis. Subsequently overlay was removed 
and cells were stained with crystal violet and plaque was counted. The viral titers were expressed as PFU/ml, cal-
culated as ((number of plaques per well) × (dilution))/(inoculum volume).
Primary neuron culture. Primary neurons were cultured according to previously published protocol20,41. 
Cells were then plated with 3 × 103cells/well in poly-D- lysine (Sigma, USA) coated 4 welled chamber slides. 
Cells were incubated with serum-free medium for 4 hour before treating with UV inactivated supernatant of 
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BV2 cell culture for 12 hours. For experimental treatments, the resting medium was exchanged for DMEM with 
N2 and B27 supplements, 25 mM KCl, and antibiotics. Mitosis inhibitor arabinoside (2 × 10−5 M) was used to 
inhibit astrocyte proliferation. Cells were treated with CHPV infected and uninfected BV2 supernatant (both 
UV treated) for 12 hour following a similar procedure for infecting HT-22 cells as mentioned previously. After 
incubation, cells were processed for TUNEL assay.
RNA isolation and real time PCR (qPCR). Mouse brain tissue and harvested BV2 cells were homogenized 
using trizol reagent as per manufacturers’ protocol (TRI reagent, Sigma, USA). For qPCR analyses, cDNA was 
synthesized using Advantage RT-for-PCR kit (Clontech laboratories, CA). Oligonucleotide primers specific for 
mouse P-Protein, iNOS, COX-2, CCL2, and IL-6 were used as mentioned in Table 1. Power SYBR Green PCR 
master mix (Applied Biosystems) was used for the experiment. The qPCR results were analysed as per the user 
manual guidelines.
Cytokine Bead Assay. The CBA kit (BD Biosciences, NJ, USA) was used to quantitatively measure cytokine 
levels in the mock-infected control and CHPV infected mouse brain samples. Using 50 μl of mouse inflammation 
standard and sample dilutions, the assay was performed according to the manufacturers’ instructions and ana-
lysed on the FACS Calibur (Becton Dickinson, CA, USA). Similar protocol was followed to analyze the cytokine 
levels for BV2 cells post CHPV infection.
Lectin Staining. Post fixation of brain tissues in 4% PFA they were subjected to cryo-sectioning. Five 
sections from each region viz. cortex, hippocampus, striatum and thalamus were stained by tomato lectin as 
described earlier42. Briefly, the cryostat sections from mock infected and CHPV infected animals were washed 
with PBS followed by quenching with 0.3% H2O2. The sections were then rinsed with PBS containing CaCl2 
(Qualigens, Thermo Fisher Scientific, USA ), MgCl2 (Merck, MA, USA), MnCl2 (Sigma, USA), and then blocked 
with 1% BSA for 1 h. Post treatment sections were incubated overnight in a humidified chamber at 4 °C with 
biotinylated-tomato Lectin (10 g/mL; Vector laboratories, USA) diluted in PBS containing CaCl2, MgCl2, MnCl2, 
and 0.1%Triton-X-100. Following incubation in Streptavidin HRP (used as the secondary antibody at 1:500; 
Vector Laboratories), the sections were further incubated in inactivated DAB for 5 minutes followed by incu-
bation in activated DAB for 10 minutes. The sections were then dehydrated in graded alcohol and xylene and 
mounted with DPX (Merck, MA, USA).
Nissl’s Staining. Five sections from each brain areas as mentioned in the previous section were stained for 
8–10 minutes cresyl violet stain followed by immersing in differentiation solution (100% alcohol + 1:1 Diaxone) 
for 4–5 minutes. Then sections were dipped in Diaxone for 3–5 minutes twice and in xylene for 3–5 minutes twice. 
Slides were mounted with coverslips using DPX (Merck, MA, USA). Then slide was kept for drying for 24 hours 
and was observed under bright field microscope.
Cell Counting. Equal area from every section was taken and cells were counted from it. Five sections were 
counted for each sample and average was calculated. Counting was done manually using ImageJ software.
Immunohistochemistry. Iba-1 (1:500, wako, USA) staining was performed on different brain region sec-
tions. Anti-Rabbit Alexa fluor 488 (1:1000; Molecular Probes, Invitrogen, USA) was probed as the secondary 
antibody of Iba-1. Fluorescence immunohistochemistry was performed for Mouse anti-Iba-1(1: 300, Chemicon, 
USA) for activated microglia which were then double stained with rabbit anti-iNOS (1:1000, Chemicon, USA) 
and rabbit anti-COX-2 (1:100, Cell Signaling Tech., Boston, USA), respectively. The corresponding secondary 
antibodies were used goat anti-mouse Alexa Fluor 594 (1:1000; Molecular Probes, OR) for Iba-1, goat anti-rabbit 
Fluorescein Isothiocyanate (FITC, 1:200; Vector Laboratories, USA) for both iNOS and COX-2. Double stain-
ing with NeuN: sections were deparaffinized, subjected to heat-induced epitope retrieval and incubated with 
NeuN antibody. After NeuN detection with an Alexa 488-labelled secondary antibody, sections were processed 
for TUNEL staining. Cell nuclei were stained with DAPI.
TUNEL assay. Mouse hippocampal cell line HT22 was plated at density of 105 cells/well in 2-well chamber 
slide with serum containing media. Cells were incubated with UV inactivated BV2 supernatant as per infection 
paradigm mentioned previously. At 12 hours post infection period, cells were subjected to In situ Cell Death 
Name of Primers Sequence of Primers
P-Protein Forward: 5′ -CACAGCTTGGAACCTTCTCC-3′  Reverse: 5′ -TGACCGGGTTGAGGATTGGC-3′ 
COX-2 Forward: 5′ -AAGGCCTCCATTGACCAG-3′  Reverse: 5′ -TCTTACAGCTCAGTTGAACGC-3′ 
iNOS Forward: 5′ -CCCTTCCGAAGTTTCTGGCAGCAGC-3′ Reverse: 5′ -GGCTGTCAGAGCCTCGTGGTGGCTTTGG-3′ 
CCL-2 Forward: 5′ -ACCAAGCTCAAGAGAGAGGT-3′  Reverse: 5′ -CTGGATTCACAGAGAGGGAA-3′ 
IL-6 Forward: 5′ -GAGGATACCACTCCCAACAGACC-3′ Reverse: 5′ -AAGTGCATCATCGTTGTTCATACA-3′ 
Table 1. Various primers with forward and reverse sequence used for experiment.
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Detection Kit, TMR red as per the manufacturers’ guidelines (Roche, Germany). Primary Neuronal cells were 
processed using similar guidelines as mentioned.
ELISA. ELISA was performed to check protein expression level of interferon. BV2 cells were cultured and 
seeded in 60 mm dish and then standard infection was followed as described earlier. Then supernatants at dif-
ferent time point was collected and ELISA was performed as protocol described. In short plate was coated with 
antibody (diluted in coating buffer to 1 μg/ml) using coating buffer and then incubated for overnight. Next day 
after blocking for an hours in blocking buffer (1% BSA in PBS) supernatant was added to each well (100 μl) and 
incubated at RT for 6 hours, followed by three PBST wash. Then secondary biotin antibody (Biolegend) was added 
in each well (100 μl diluted in blocking solution 1 μg/ml), and incubated at RT for 30 minutes followed by three 
PBST wash and then incubation with streptavidin (Vector laboratories) for 30 minutes at RT. Substrate (TMB 
solution, Vector laboratories) was added and was incubated for 20 minutes and then stop solution was added for 
100 μl per well. Optical Density was measured at 450 nm.
Immunoblotting. Supernatant treated HT-22 cells were harvested for obtaining total cellular extracts, and 
the protein isolation procedure and immunoblotting steps were performed according to standard procedure. 
After being blocked with 5% skimmed milk, the membranes were incubated with primary antibodies against 
cleaved caspase-3 (Abcam, USA), at 1:1,000 dilutions. After extensive washes with 0.1% PBS-Tween, blots were 
incubated with the Anti-Rabbit peroxidase-conjugated secondary antibodies (Vector Laboratories, USA). The 
blots were processed for development using chemiluminescence reagent (Millipore, USA). The images were cap-
tured and analyzed using the Chemigenius bioimaging system (Syngene, United Kingdom). β -actin antibody 
(Sigma , USA) at 1:10,000 dilution was used as loading control.
ROS Measurement. Intracellular ROS generation in control and treated cells was assessed using the cell 
permeable, non-polar H2O2 sensitive dye 5-(and-6)-chlromethyl-2′ , 7′ - dichloro dihydro fluorescein diacetate 
(CM-H2DCFDA) (Sigma Aldrich, USA) as described previously41. The extent to which H2O2 is generated is 
defined as the extent of ROS generation. Briefly, BV-2 cells were mock and CHPV infected for different time 
point. This was further followed with incubation in serum free media for 3 hour. Upon treatment, the cells were 
further treated with H2DCFDA (5 μM) for 30 minutes at 37 °C. Cells were washed twice with 1 × PBS and flu-
orescent intensity of the cells was measured using Varioskan flash multimode plate reader. To detect ROS from 
whole brain lysate, fresh brain homogenate sample were taken and incubated with DCFDA (5 μM) for 30 minutes 
at room temperature.
Nitric oxide (NO) assay. Nitric oxide released from brain homogenates following CHPV infection was 
assessed using Griess reagent as described previously. Briefly, 100 μL of Griess reagent (Sigma, St. Louis, USA) was 
added to 100 μL of brain homogenate and incubated in dark for 15 minutes. The intensity of the color developed 
was estimated at 540 nm with the help of a Benchmark plus 96-well ELISA plate reader (Biorad, CA, USA). The 
amount of nitrite accumulated was calculated (in μM) from a standard curve constructed with different concen-
trations of sodium nitrite40.
Statistical analysis. Values were calculated as the means of n = 3 independent experiments taking into con-
sideration both − ve and + ve standard deviation (SD). In case of in vivo experiments each experimental groups 
consisted of 5 animals. Data from both mock-infected and experimental samples were compared using one-tailed 
Student’s t test in Graph Pad Prism 5 software. Statistical significance was set at p values of < 0.05 for all analyses.
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